# US 2018/0251442 A1 · Processes and intermediates for the preparations of isomer free prostaglandins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0251442 A1
- Document ID: US20180251442A1
- Status: Published application
- Kind: A1
- Application number: 15/970,067
- Filed: 2018-05-03
- Published: 2018-09-06
- Earliest claimed: 2013-08-15
- Assignees: Chirogate International Inc.
- Applicants: Chirogate International Inc.
- Inventors: Shih-Yi Wei; Yu-Chih Yeh; Min-Kuan Hsu; Li-Ta Kao
- Web page: https://patentgrep.com/patent/US20180251442A1

## CPC

- C07D 313/00: Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- A61P 27/06: Antiglaucoma agents or miotics
- C07C 51/347: by reactions not involving formation of carboxyl groups
- C07C 59/72: containing six-membered aromatic rings and other rings
- C07C 67/10: by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond (preparation from carboxylic acid halides C07C67/14)
- C07C 69/608: Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
- C07C 69/618: having unsaturation outside the six-membered aromatic ring
- C07C 231/02: from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
- C07C 405/00: Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins {; Analogues or derivatives thereof}
- C07C 405/0016: {containing only hydroxy, etherified or esterified hydroxy groups}
- C07C 405/0041: {containing nitrogen}
- C07D 309/12: only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C07D 407/12: linked by a chain containing hetero atoms as chain links
- C07D 407/14: containing three or more hetero rings
- C07F 7/1804: {Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896)}
- C07C 2601/08: the ring being saturated
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: wherein R2, R3 and R4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.

## Claims

### Claim 1

Latanoprost containing a non-detectable level of 5,6-trans isomer and 15β-isomer as determined by HPLC method, the limit of detection of HPLC method being more than 0.02%.

### Claim 2

Travoprost containing a non-detectable level of 5,6-trans isomer and 15β-isomer as determined by HPLC method, the limit of detection of HPLC method being more than 0.02%.

### Claim 3

Tafluprost containing a non-detectable level of 5,6-trans isomer as determined by HPLC method, the limit of detection of HPLC method being more than 0.02%.

### Claim 4

Isopropyl Unoprostone containing a non-detectable level of 5,6-trans isomer as determined by HPLC method, the limit of detection of HPLC method being more than 0.020%.
